{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:18:19Z","timestamp":1793859499202,"version":"4.6.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100018540","name":"Science Fund for Distinguished Young Scholars of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515140154"],"award-info":[{"award-number":["2022A1515140154"]}],"id":[{"id":"10.13039\/501100018540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-024-05662-1","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T05:01:58Z","timestamp":1727672518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Oral colon-targeted pH-responsive polymeric nanoparticles loading naringin for enhanced ulcerative colitis therapy"],"prefix":"10.1186","volume":"22","author":[{"given":"Shilong","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinlian","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Pi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1149-4531","authenticated-orcid":false,"given":"Zhikun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"key":"5662_CR1","doi-asserted-by":"publisher","first-page":"100851","DOI":"10.1016\/j.disamonth.2019.02.004","volume":"65","author":"M Gajendran","year":"2019","unstructured":"Gajendran M, Loganathan P, Jimenez G, Catinella AP, Ng N, Umapathy C, Ziade N, Hashash JG. A comprehensive review and update on ulcerative colitis(). Dis Mon. 2019;65:100851.","journal-title":"Dis Mon"},{"key":"5662_CR2","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/S0140-6736(12)60150-0","volume":"380","author":"I Ord\u00e1s","year":"2012","unstructured":"Ord\u00e1s I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet. 2012;380:1606\u201319.","journal-title":"Lancet"},{"key":"5662_CR3","doi-asserted-by":"crossref","unstructured":"Perrotta C, Pellegrino P, Moroni E, De Palma C, Cervia D, Danelli P, Clementi E. Five-aminosalicylic Acid: an update for the reappraisal of an old drug. Gastroenterol Res Pract 2015, 2015:456895.","DOI":"10.1155\/2015\/456895"},{"key":"5662_CR4","doi-asserted-by":"publisher","first-page":"691480","DOI":"10.3389\/fimmu.2021.691480","volume":"12","author":"S Bruscoli","year":"2021","unstructured":"Bruscoli S, Febo M, Riccardi C, Migliorati G. Glucocorticoid therapy in inflammatory bowel disease: mechanisms and clinical practice. Front Immunol. 2021;12:691480.","journal-title":"Front Immunol"},{"key":"5662_CR5","doi-asserted-by":"crossref","unstructured":"Kayal M, Shah S. Ulcerative Colitis: current and emerging treatment strategies. J Clin Med 2019, 9.","DOI":"10.3390\/jcm9010094"},{"key":"5662_CR6","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1093\/ibd\/izy123","volume":"24","author":"M Zhang","year":"2018","unstructured":"Zhang M, Merlin D. Nanoparticle-based oral drug Delivery systems Targeting the Colon for treatment of Ulcerative Colitis. Inflamm Bowel Dis. 2018;24:1401\u201315.","journal-title":"Inflamm Bowel Dis"},{"key":"5662_CR7","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41419-021-03778-6","volume":"12","author":"L Liu","year":"2021","unstructured":"Liu L, Wu Y, Wang B, Jiang Y, Lin L, Li X, Yang S. DA-DRD5 signaling controls colitis by regulating colonic M1\/M2 macrophage polarization. Cell Death Dis. 2021;12:500.","journal-title":"Cell Death Dis"},{"key":"5662_CR8","doi-asserted-by":"publisher","first-page":"174742","DOI":"10.1016\/j.ejphar.2022.174742","volume":"917","author":"J Long","year":"2022","unstructured":"Long J, Liu XK, Kang ZP, Wang MX, Zhao HM, Huang JQ, Xiao QP, Liu DY, Zhong YB. Ginsenoside Rg1 ameliorated experimental colitis by regulating the balance of M1\/M2 macrophage polarization and the homeostasis of intestinal flora. Eur J Pharmacol. 2022;917:174742.","journal-title":"Eur J Pharmacol"},{"key":"5662_CR9","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.omtn.2021.07.005","volume":"25","author":"ZL Li","year":"2021","unstructured":"Li ZL, Yang BC, Gao M, Xiao XF, Zhao SP, Liu ZL. Naringin improves sepsis-induced intestinal injury by modulating macrophage polarization via PPAR\u03b3\/miR-21 axis. Mol Ther Nucleic Acids. 2021;25:502\u201314.","journal-title":"Mol Ther Nucleic Acids"},{"key":"5662_CR10","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/tox.23774","volume":"38","author":"K Ma","year":"2023","unstructured":"Ma K, Liu W, Liu Q, Hu P, Bai L, Yu M, Yang Y. Naringenin facilitates M2 macrophage polarization after myocardial ischemia-reperfusion by promoting nuclear translocation of transcription factor EB and inhibiting the NLRP3 inflammasome pathway. Environ Toxicol. 2023;38:1405\u201319.","journal-title":"Environ Toxicol"},{"key":"5662_CR11","doi-asserted-by":"publisher","first-page":"558741","DOI":"10.3389\/fphar.2020.558741","volume":"11","author":"J Shi","year":"2020","unstructured":"Shi J, Li J, Xu Z, Chen L, Luo R, Zhang C, Gao F, Zhang J, Fu C. Celastrol: a review of useful strategies overcoming its limitation in Anticancer Application. Front Pharmacol. 2020;11:558741.","journal-title":"Front Pharmacol"},{"key":"5662_CR12","doi-asserted-by":"publisher","first-page":"13133","DOI":"10.1021\/acs.jafc.8b03942","volume":"66","author":"H Cao","year":"2018","unstructured":"Cao H, Liu J, Shen P, Cai J, Han Y, Zhu K, Fu Y, Zhang N, Zhang Z, Cao Y. Protective effect of Naringin on DSS-Induced Ulcerative Colitis in mice. J Agric Food Chem. 2018;66:13133\u201340.","journal-title":"J Agric Food Chem"},{"key":"5662_CR13","doi-asserted-by":"publisher","first-page":"113887","DOI":"10.1016\/j.addr.2021.113887","volume":"176","author":"M Zu","year":"2021","unstructured":"Zu M, Ma Y, Cannup B, Xie D, Jung Y, Zhang J, Yang C, Gao F, Merlin D, Xiao B. Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases. Adv Drug Deliv Rev. 2021;176:113887.","journal-title":"Adv Drug Deliv Rev"},{"key":"5662_CR14","doi-asserted-by":"publisher","first-page":"16365","DOI":"10.1039\/C7NR06898K","volume":"9","author":"H Jin","year":"2017","unstructured":"Jin H, Pi J, Zhao Y, Jiang J, Li T, Zeng X, Yang P, Evans CE, Cai J. EGFR-targeting PLGA-PEG nanoparticles as a curcumin delivery system for breast cancer therapy. Nanoscale. 2017;9:16365\u201374.","journal-title":"Nanoscale"},{"key":"5662_CR15","doi-asserted-by":"publisher","first-page":"1050224","DOI":"10.3389\/fphar.2022.1050224","volume":"13","author":"H Jin","year":"2022","unstructured":"Jin H, Luo R, Li J, Zhao H, Ouyang S, Yao Y, Chen D, Ling Z, Zhu W, Chen M, et al. Inhaled platelet vesicle-decoyed biomimetic nanoparticles attenuate inflammatory lung injury. Front Pharmacol. 2022;13:1050224.","journal-title":"Front Pharmacol"},{"key":"5662_CR16","doi-asserted-by":"crossref","unstructured":"Hidalgo-Cantabrana C, Algieri F, Rodriguez-Nogales A, Vezza T, Mart\u00ednez-Camblor P, Margolles A, Ruas-Madiedo P, G\u00e1lvez J. Effect of a Ropy Exopolysaccharide-Producing Bifidobacterium animalis subsp. lactis strain orally administered on DSS-Induced Colitis mice Model. Front Microbiol 2016, 7.","DOI":"10.3389\/fmicb.2016.00868"},{"key":"5662_CR17","doi-asserted-by":"publisher","first-page":"110486","DOI":"10.1016\/j.biopha.2020.110486","volume":"129","author":"X Li","year":"2020","unstructured":"Li X, Lu C, Yang Y, Yu C, Rao Y. Site-specific targeted drug delivery systems for the treatment of inflammatory bowel disease. Biomed Pharmacother. 2020;129:110486.","journal-title":"Biomed Pharmacother"},{"key":"5662_CR18","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1007\/s11434-016-1056-4","volume":"61","author":"L Lu","year":"2016","unstructured":"Lu L, Chen G, Qiu Y, Li M, Liu D, Hu D, Gu X, Xiao Z. Nanoparticle-based oral delivery systems for colon targeting: principles and design strategies. Sci Bull. 2016;61:670\u201381.","journal-title":"Sci Bull"},{"key":"5662_CR19","doi-asserted-by":"publisher","first-page":"5853","DOI":"10.1039\/D2TB01190E","volume":"10","author":"DF Li","year":"2022","unstructured":"Li DF, Yang MF, Xu HM, Zhu MZ, Zhang Y, Tian CM, Nie YQ, Wang JY, Liang YJ, Yao J, Wang LS. Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease. J Mater Chem B. 2022;10:5853\u201372.","journal-title":"J Mater Chem B"},{"key":"5662_CR20","doi-asserted-by":"publisher","first-page":"e2301585","DOI":"10.1002\/adma.202301585","volume":"35","author":"X Song","year":"2023","unstructured":"Song X, Huang Q, Yang Y, Ma L, Liu W, Ou C, Chen Q, Zhao T, Xiao Z, Wang M, et al. Efficient therapy of inflammatory bowel disease (IBD) with highly specific and durable targeted Ta(2) C modified with chondroitin sulfate (TACS). Adv Mater. 2023;35:e2301585.","journal-title":"Adv Mater"},{"key":"5662_CR21","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ijpharm.2018.11.049","volume":"555","author":"H-Y Zhang","year":"2019","unstructured":"Zhang H-Y, Sun C-y, Adu-Frimpong M, Yu J-n. Xu X-m: glutathione-sensitive PEGylated curcumin prodrug nanomicelles: Preparation, characterization, cellular uptake and bioavailability evaluation. Int J Pharm. 2019;555:270\u20139.","journal-title":"Int J Pharm"},{"key":"5662_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/toxsci\/kfr149","volume":"123","author":"J Choi","year":"2011","unstructured":"Choi J, Reipa V, Hitchins VM, Goering PL, Malinauskas RA. Physicochemical characterization and in vitro hemolysis evaluation of silver nanoparticles. Toxicol Sci. 2011;123:133\u201343.","journal-title":"Toxicol Sci"},{"key":"5662_CR23","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41575-019-0172-4","volume":"16","author":"YR Na","year":"2019","unstructured":"Na YR, Stakenborg M, Seok SH, Matteoli G. Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD. Nat Rev Gastroenterol Hepatol. 2019;16:531\u201343.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5662_CR24","doi-asserted-by":"crossref","unstructured":"Kim JJ, Shajib MS, Manocha MM, Khan WI. Investigating intestinal inflammation in DSS-induced model of IBD. J Vis Exp 2012.","DOI":"10.3791\/3678"},{"key":"5662_CR25","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.molmed.2020.06.006","volume":"26","author":"AR Bourgonje","year":"2020","unstructured":"Bourgonje AR, Feelisch M, Faber KN, Pasch A, Dijkstra G, van Goor H. Oxidative stress and redox-modulating therapeutics in inflammatory bowel disease. Trends Mol Med. 2020;26:1034\u201346.","journal-title":"Trends Mol Med"},{"key":"5662_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cytogfr.2021.03.003","volume":"60","author":"Y Song","year":"2021","unstructured":"Song Y, Zhao Y, Ma Y, Wang Z, Rong L, Wang B, Zhang N. Biological functions of NLRP3 inflammasome: a therapeutic target in inflammatory bowel disease. Cytokine Growth Factor Rev. 2021;60:61\u201375.","journal-title":"Cytokine Growth Factor Rev"},{"key":"5662_CR27","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3109\/00365520903301212","volume":"44","author":"JB Seidelin","year":"2009","unstructured":"Seidelin JB, Nielsen OH. Epithelial apoptosis: cause or consequence of ulcerative colitis? Scand J Gastroenterol. 2009;44:1429\u201334.","journal-title":"Scand J Gastroenterol"},{"key":"5662_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","volume":"7","author":"K Hou","year":"2022","unstructured":"Hou K, Wu ZX, Chen XY, Wang JQ, Zhang D, Xiao C, Zhu D, Koya JB, Wei L, Li J, Chen ZS. Microbiota in health and diseases. Signal Transduct Target Ther. 2022;7:135.","journal-title":"Signal Transduct Target Ther"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05662-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05662-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05662-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T05:04:40Z","timestamp":1727672680000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05662-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5662"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05662-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,30]]},"assertion":[{"value":"22 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Experimental procedures using mice in this study were reviewed and approved by the ethical review board of Guangdong Medical University, and all the experiments were performed in accordance with relevant guidelines and regulations of Animal Ethics Committee of Guangdong Province, China. Animals and protocol were approved by the Ethics Committee of Guangdong Medical University (GDY2002004).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"878"}}